Skip to main content

Author: Tracy McQuire

Tom Weisz: A Patient Partner Who Kept Us Moving from Knowing to Doing

For nearly a decade with Diabetes Action Canada, Tom helped push foot care forward, asked the hard questions, and reminded us that real impact takes teamwork and persistence. As he retires from the Network, Tom sat down with DAC Executive Director Tracy McQuire to reflect on what he’s learned, what he’s helped shape, and the questions he’s carrying into this next chapter.

Some people change a network with a big, sweeping idea. Tom Weisz changed ours by doing something quieter and often harder: showing up, staying curious, and refusing to let important work stall at “good conversation.”

Tom has been part of Diabetes Action Canada (DAC) since the early days. As he steps back from his formal Patient Partner role, we wanted to pause and say thank you not just for what he contributed, but also for how he contributed: with humour, honesty, and a steady insistence that knowledge only matters if it leads to action.

“Knowing without acting is effectively meaningless.” – Tom Weisz

What brought Tom to DAC

Tom did not come to patient partnership looking for a title. He came because someone challenged him not to waste what he had learned.

Just before he retired from his professional career as a podiatrist, a nurse colleague offered a piece of advice Tom still carries: do not stop contributing just because you are retiring. Around that same time, he was publishing and presenting on diabetic foot care work that put him in rooms where policy, practice, and lived experience collided.

One moment still makes him laugh: attending a conference, hearing a speaker reference “a small article that sums it up nicely,” and realizing the article on the screen was his. That speaker was Dr. Charles de Mestral, and it sparked a connection that brought Tom into DAC’s growing community.

“Next thing I know, I was involved in this, that, and the other,” Tom said — a classic understatement.

A champion for foot care and the long game of change

Many people across DAC know Tom through his contributions to foot care and lower limb preservation work. He has helped keep the reality of complications on the agenda; not to scare people, but to be clear-eyed about what prevention can protect.

Tom’s approach is direct, grounded, and shaped by experience. He understands how easily diabetes complications can be minimized until they become urgent and how hard it can be to shift systems before that moment arrives.

But he also understands something else: change is rarely a single event. It is often a slow build.

Tom described it like this: you can chip away for a long time and only see tiny changes — until one day, you hit the right point and a whole section finally moves. For anyone who has worked on policy, funding, or practice change, the analogy lands.

A learner by nature — and a connector by instinct

If you ask Tom what stood out most over the years, he does not start with accomplishments. He starts with people.

“Without fail,” he said, “there’s not an individual who I’ve come across… that I wouldn’t love to break bread with.”

Tom talked about how much he learned through DAC, not only about different types of diabetes, but about broader realities that shape health outcomes: the health inequities experienced by Indigenous Peoples, stigma, access, and the everyday barriers people face navigating care. His default setting is curiosity, and he treats “I don’t know” as an invitation, not a weakness.

“Everybody knows something you don’t know.”

That mindset made him a steady presence in patient partnership spaces where DAC teams bring ideas, tools, and drafts to be tested, not just for whether they are “good,” but whether they will actually work in real life.

The role Tom played: the question-asker who sharpened the work

Tom often described himself as not being part of the “organizational” side.  He was not seeking to run processes. Instead, he was the person you brought something to when you needed it pressure-tested.

As a member of the DAC Collective Patient Circle, he valued this group as a safe place for people to disagree, to speak up, and to improve ideas early before they became finished products that were harder to change.

And he noticed something important: over time, people got more comfortable naming what didn’t work, not just what did.

That ability to surface what is missing, to ask the question that unlocks the next step, is one of Tom’s gifts. It shaped projects in visible and invisible ways, including DAC’s Research to Action Fellowship (where his feedback helped strengthen the program design) as well as the Patient Partner Recruitment process.

Tom’s “secret sauce” for patient partnership

When asked what makes patient engagement work, Tom did not give a slogan. He gave a practical recipe:

  • Be clear on your target — know what you are actually trying to change.
  • Do not insist on one route — there are “a bazillion ways” to get there.
  • Do not “hear” the word no — expect it, and keep going anyway.
  • Build up the team — you will not do it alone.

He compared it to sport: a good play only works when everyone does his or her part. The “stars” might get the spotlight, but the outcome depends on the whole team.

And he named the truth that patient partners often know best: this work takes time and sometimes progress arrives in bursts after long stretches of slow effort.

Life shifts — and why Tom is stepping back (for now)

Tom is retiring from his formal DAC role due to a shift in health priorities. He shared openly that he and his wife have been navigating long COVID, and that energy is now the limiting factor, not commitment.

As Tom steps back, he is not stepping away from questions that matter. He is turning his attention to a growing and complicated intersection: diabetes and long COVID. For him, the tension is practical—diabetes care often emphasizes exercise, while long COVID can make physical activity unpredictable or impossible. It is a gap he is actively trying to understand, and one he hopes the research community will take seriously and study in depth.

“As someone with diabetes, you’re always told exercise matters for blood glucose. But with long COVID not everyone can exercise. That’s where I’m looking now: what does good care look like when diabetes guidance and long COVID realities don’t line up?”

For Tom, the question is ultimately clinical: what can physicians actually offer; what can they say or do when a person is living with both diabetes and long COVID, and the usual tools (like exercise) don’t apply? He’s hopeful for practical guidance that improves day-to-day health and he is candid about the urgency: he doesn’t want it to take 15 years for emerging evidence to reach the clinic door.

Even as he steps back, Tom’s identity as a contributor has not changed. He still reads widely, follows emerging evidence, and shares articles when something feels important, especially when it connects diabetes with broader health issues.

And while he’s stepping away from committee responsibilities, his message to DAC was simple: he’ll miss the people, and he hopes to re-engage when he can.

Thank you, Tom

Tom, thank you for nearly a decade of partnership, for helping elevate foot care and prevention, for asking the questions that made our work better, and for reminding all of us that progress is only progress when it turns into action.

We are grateful — and we’re keeping a seat open for you.

Calls to action


Congratulations to DAC Researchers Funded Through Diabetes Canada Awards

Strong ideas rise to the top in competitive funding rounds and this year’s Diabetes Canada competition was no exception. With 13 awards funded from 135 applications, the bar was high. Against that backdrop, five of the 13 funded awards (38%) were led by DAC members.

DAC supported 14 of the submitted applications, with three funded, representing a success rate of more than 21% for DAC-supported submissions. Congratulations to David Campbell, Annalijn Conklin, and Mahavir Agarwal, whose projects were supported by DAC.

Projects funded:

  • Does impaired brain insulin action underlie the shared risk of depression and diabetes? A neuroimaging clinical trial
    • Led by Mahavir Agarwal
  • Can social connections help protect against the risk of diabetes and its physical and mental health complications?
    • Led by Annalijn Conklin
  • Enhancing food skills among people exiting homelessness
    • Led by David Campbell

We also celebrate DAC members Bruce Verchere and Dylan MacKay, who were funded through this competition as well.

Projects funded:

  • Can type 2 diabetes remission be achieved with the help of a diabetes medication that works for weight loss
    • Led by Dr. Dylan MacKay
  • Fixing insulin production in type 1 diabetes 
    • Led by Dr. Bruce Verchere

Every project funded through this competition addresses an important aspect of diabetes research. We congratulate all of this year’s award recipients and are proud to see DAC members contributing to such a strong and diverse portfolio of work.

Learn more about Diabetes Canada’s funded research: https://www.diabetes.ca/research/research-funding/currently-funded-research

Research to Action Fellowship and Knowledge Mobilization in Focus at DAC’s January Network Action Session

On January 12, 2026, Diabetes Action Canada (DAC) hosted its latest Network Action Session, bringing together researchers, Patient Partners, trainees, and community leaders from across the country to share progress, test ideas, and connect evidence to action across the Network.

Research to Action Fellowship: Turning Evidence into Tools

We kicked off the session with an update on the Research to Action Fellowship, led by Linxi Mytkolli, Director of Patient Engagement, highlighting how Fellows and partners are producing concrete, patient-driven tools to move research into real-world use.This year’s Fellowship projects focus on:

  • diabetes stigma
  • misdiagnosis and self-advocacy
  • women’s health and diabetes
  • cell therapy education
  • diabetes technology decision-making

These projects are being developed in partnership with organizations including the Australian Centre for Behavioural Research in Diabetes, Indigenous Diabetes Health Circle, Tidepool, Alberta Diabetes Institute, and Children with Diabetes, ensuring each output is grounded in both evidence and lived experience.

Members were invited to review and contribute to these tools as they are being developed:
👉 https://linktr.ee/diabetesactioncanada

Diabetes Remission: Knowledge Mobilization in Practice

The session also featured a diabetes remission presentation from Dr. Diana Sherifali and Dr. Monika Kastner, using remission as a real-world case study to demonstrate DAC’s Knowledge Mobilization (KM) model in action. The team showed how complex and often inconsistent research evidence is translated into practical, usable outputs for patients, providers, and health systems.

Participants were walked through how the research team:

  • maps what evidence exists on remission,
  • identifies gaps and inconsistencies,
  • integrates patient experience to clarify what the data means in real life, and
  • translates insights into resources, messaging, and care-support tools.

This case study demonstrated why remission cannot be treated as a single clinical outcome, but must be supported by clear definitions, patient-centred communication, and decision-support tools that people can actually use in care.

👉 Learn more about DAC’s remission research and resources:
https://diabetesaction.ca/understanding-type-2-diabetes-remission-new-research-new-resources/

👉 Explore DAC’s Knowledge Mobilization tools and practice resources:
https://diabetesaction.ca/common-knowledge-translation-mobilization-and-implementation-science-km-is-practice-tools/

Missed the session?

🎥 Watch the full recording here


Featured Resources & Initiatives

Optimizing patient partner engagement and integration in research
A new paper in the Canadian Journal of Diabetes led by DAC researchers and Patient Partners reports what people living with diabetes say meaningful partnership in research really requires — and what needs to change to make it work better.
👉 Read the article: https://pubmed.ncbi.nlm.nih.gov/41386479/

DAC 2025 Year in Review
Explore highlights from across the Network, including Research to Action Fellowship projects, new publications, and major partnerships.
👉 Read the recap: https://diabetesaction.ca/dac2025recap/


Upcoming Event

Global End Diabetes Stigma Summit — March 28–29, 2026 (Jaipur, India)
Linxi Mytkolli is serving on the Steering Committee for the Global End Diabetes Stigma Summit, working with Patient Partners and researchers across Canada to elevate both DAC’s work and broader diabetes-related stigma efforts on the international stage. With a record number of DAC Patient Partners invited, we’re supporting this group to bring strong, patient-centred voices to the Summit.


Stay Connected

Follow DAC on LinkedIn
Visit our website

Thank you to everyone who took part in this session and helped push this work forward. We look forward to staying connected as these projects and resources continue to take shape.

Putting Lived Experience at the Centre of Diabetes Research

Diabetes Action Canada (DAC) was built on a simple idea: research works better when the people most affected by it help shape it. But even with that commitment, we kept asking ourselves an important question, are we really doing patient engagement as well as we could be?

A new paper published in the Canadian Journal of Diabetes takes a deep look at that question. Led by DAC researchers and Patient Partners, Optimizing patient partner engagement and integration in research shares what people living with diabetes told us about what meaningful partnership in research actually looks like and what needs to change to make it work better.

👉 Read the full article: https://pubmed.ncbi.nlm.nih.gov/41386479/

Why we did this study

Diabetes affects millions of people, but the burden is not shared equally. People facing racism, poverty, language barriers, stigma, or limited access to care often experience the worst outcomes. Patient-oriented research is meant to help close those gaps by making sure research reflects real-world needs, but too often, patient involvement becomes rushed, unclear, or tokenistic.

We wanted to move beyond good intentions. We wanted to learn directly from the people doing this work with us: our Patient Partners.

What we did

In 2022, DAC brought together 35 Patient Partners from across Canada (in English and French) living with Type 1 or Type 2 diabetes, and with a wide range of backgrounds and experiences. Through 13 focus groups, participants shared what it’s really like to be part of a research team: what helps them contribute, what makes them feel valued, and what gets in the way.

Two Patient Partners were also part of the research team from the start. They helped design the study, interpret the findings, and are co-authors on the paper, a reflection of DAC’s commitment to research done with patients, not just about them.

What Patient Partners told us

Patient Partners were clear about what meaningful engagement feels like. It starts with being respected, heard, and valued, not just invited to a meeting, but treated as an equal member of the team. It also means having relationships with researchers, being supported, and being able to learn and share knowledge in both directions.

Most importantly, engagement feels meaningful when people can see that their input makes a difference. When research results are shared, acted on, and reach the communities they are meant to serve.

At the same time, participants were honest about where things don’t always work well. Some described confusion about how to join projects or what their role was supposed to be. Others felt overwhelmed by jargon, left out of decisions, or unsure whether their contributions were truly being used.

Living with diabetes adds another layer. Managing blood sugars, complications, fatigue, stress, and stigma can make it hard to commit time and energy, even when people are deeply motivated to give back. Participants spoke about the emotional toll of diabetes, the need for flexibility, and the importance of cultural and language-appropriate support.

A new way of thinking about patient engagement

One of the most important insights from this study is that patient engagement is not one-size-fits-all. What people need before a study begins is different from what they need once a project is underway, or when it comes time to share the results.

Based on what Patient Partners shared, the research team developed a research-stage-specific engagement framework that outlines how patients and researchers can be better supported:

  • Before a project – making it easier to find opportunities and be matched to the right work
  • At the start – clear onboarding, plain-language project summaries, and defined roles
  • Throughout – regular communication, flexible ways to contribute, and shared decision-making
  • At the end – recognition, authorship, and feedback on how patient input shaped the work

This approach moves beyond abstract principles and offers practical guidance that research teams can actually use.

How this research shaped DAC’s Phase 2

This study was not done in isolation. The focus groups took place at a pivotal moment for Diabetes Action Canada, just as the Network was preparing to move from its first phase into Phase 2 (2022–2026). That timing meant the findings were not only academic; they were immediately actionable.

As early findings came in, DAC leaders, staff, and Patient Partners used them to reflect on what was working and what needed to change. Clear themes emerged around the need for better onboarding, clearer roles, stronger communication, and more flexible and equitable ways for people to contribute. Those insights directly influenced how DAC designed and strengthened its Patient Engagement Program for Phase 2, from how Patient Partners are matched to projects to how they are supported throughout the research process.

In other words, this research did not just study DAC’s engagement model, it actively shaped it. The framework presented in this paper reflects both what Patient Partners told us and how DAC responded, making Phase 2 more grounded in lived experience, more accessible, and more aligned with what meaningful partnership actually requires.

DAC Year in Review


Thank You for Another Year of Moving Diabetes Research into Action (2025)

As we close out 2025, we want to say thank you to everyone who is part of the Diabetes Action Canada (DAC) Network. This work moves forward because people show up, with their expertise, lived experience, and a real willingness to work together across disciplines and sectors.

The holidays are a chance to slow down and recharge, but it is also a moment to look back on the year we have had and what is ahead. We have accomplished a lot together, and I wanted to share a few highlights with you here.

2025 Highlights

  • Published three DAC-led papers on patient-oriented research and patient engagement, including the 4Ls Framework (Diabetes in Four Dialects).
  • Research-to-Action Fellowship resources from our inaugural cohort surpassed 100,000 downloads across 130 countries.
  • Welcomed a new Fellowship cohort and launched this year’s projects at the Diabetes Canada Conference in November 2025.
  • Deepened our partnership with the Indigenous Diabetes Health Circle (IDHC), including signing a collaborative relationship agreement in Thorold, Ontario.
  • Hosted three DAC Network Action Sessions on diabetes remission, peer support in type 1 diabetes, and islet and stem cell innovation.
  • Save the date: our next Network Action Session is January 12, 2026 at 2:00 PM ET (Best Practices in Knowledge Mobilization with Drs. Monika Kastner and Diana Sherifali).

Evidence and Community Learning in 2025

Publications

This year, DAC published several papers that reflect how we approach patient-oriented research in practice. The 4Ls paper gives us a common way to talk about why lived, loved, learned, and laboured experience matters in shaping better research and care. Our Workshop paper reflects on eight years of planning academic meetings alongside Patient Partners and what we’ve learned along the way. We also released a new paper that looks at how Patient Partner feedback and co-design helped us strengthen the DAC Patient Engagement Program as the Network evolved. It’s been meaningful to see this work resonate, with these papers downloaded more than 2,000 times so far.

Read: Diabetes in Four Dialects (4Ls Framework) 👉: Diabetes in Four Dialects: A Global Call for Equity
Read: Partnering for Impact (Workshop paper) 👉: Partnering for impact: best practices for planning in-person academic events with Patient Partners involvement– Lessons learned from Diabetes Action Canada
Read: Optimizing patient partner engagement and integration in research (Patient Partner feedback + co-design)👉: Optimizing patient partner engagement and integration in research

Community learning and conferences

We spent a lot of this past year connecting with the broader diabetes and health research community, including at the Diabetes Canada Professional Conference, American Diabetes Association (ADA), International Diabetes Federation (IDF), Research Canada, International Society for Pediatric and Adolescent Diabetes (ISPAD), National Indigenous Diabetes Association (NIDA), Canadian Association for Health Services and Policy Research (CAHSPR), and the TIMED Consortium meeting in the Netherlands, to name a few.

These spaces matter. They are where ideas are tested, partnerships take place, and help us stay focused on issues that matter to patients, providers, and communities.

Capacity-Building and Key Partnerships

Research-to-Action Fellowship

The Research-to-Action Fellowship has become a cornerstone of DAC’s work and is shaped from start to finish with our Patient Partners. In the inaugural cohort, Fellows worked with community and health organizations to co-create practical resources (found here), including self-advocacy tools, comics, culturally tailored education materials, and infographics, all grounded in lived experience and community priorities. These projects were featured at eight national and international conferences and have been downloaded more than 100,000 times across 130 countries.

In May, we welcomed a new Fellowship cohort, who will complete their projects in January 2026. Showcased at the Diabetes Canada Conference in November 2025, this year’s projects focus on diabetes stigma, misdiagnosis and self-advocacy, women’s health and diabetes, cell therapy education, and diabetes technology decision-making. Partner organizations include the Australian Centre for Behavioural Research in Diabetes, Indigenous Diabetes Health Circle, Tidepool, Alberta Diabetes Institute, and Children with Diabetes.

A selection of tools is available for early testing here👉: https://linktr.ee/diabetesactioncanada

Indigenous Diabetes Health Circle Partnership

This year, we continued to deepen our long-standing partnership with the Indigenous Diabetes Health Circle (IDHC) and formally signed a collaborative relationship agreement at their head office in Thorold, Ontario.

Our work together spans many years and initiatives, including diabetic retinopathy screening, lower limb preservation, and collaboration through the Research-to-Action Fellowship. This relationship is grounded in trust, reciprocity, and a shared commitment to Indigenous-led approaches to diabetes wellness.

Over the past year, it has continued to grow through our involvement in Karihwahstha, an Indigenous-governed initiative supporting culturally grounded diabetes care, knowledge sharing, and community-defined priorities. We are grateful for IDHC’s leadership and guidance and for the opportunity to continue walking this path together.

From Conversation to Action

This year, DAC hosted three Network Action Sessions, bringing patient partners, researchers, clinicians, and system leaders together to focus on shared priorities and practical next steps.

Together, we explored islet and stem cell innovation, diabetes remission, and peer support in type 1 diabetes, grounding conversations in lived experience, feasibility, and impact. The goal was simple: connect evidence to lived experience and identify what could realistically move forward.

Missed a session? You can find short summaries and the YouTube recordings here:

Diabetes Remission: An Implementation and Knowledge Mobilization Opportunity
CommuniT1D / CommunauDT1
Islet & Stem Cell Transplants for Diabetes: Fact, Fiction, or Fantasy?

Save the date! Our next Network Action Session is on January 12, 2026 at 2:00 PM ET, featuring Drs. Monika Kastner and Diana Sherifali.

We’ll take a practical look at Best Practices in Knowledge Mobilization: A Case Study in Type 2 Diabetes Remission, and explore how DAC’s knowledge mobilization program helps move evidence into community settings.

Register here 👉: https://us06web.zoom.us/meeting/register/KfilbfVXQwmYj12WoO8pzQ

Selected DAC-supported Publications (2025)

DAC supports research across the supports diabetes research through our patient engagement, digital health, and knowledge mobilization programs. This work is driven by people across the Network who bring lived experience and expertise to the questions being explored.

Below are a few examples of publications DAC contributed to this year. These publications span type 1 diabetes, type 2 diabetes, complications, health services, and equity.

Looking Ahead

Global End Diabetes Stigma Summit (March 2026)

In 2026, our team is contributing to planning and Canadian representation at the Global End Stigma Summit (March 28–29, 2026), in Jaipur, India. It’s an opportunity to share what we’re learning in Canada and learn alongside partners working to change how diabetes is understood and discussed.

In November, we submitted our application to CIHR for continued funding for Diabetes Action Canada over the next two years. We are grateful to see strong partner commitment and new partners joining the Network. More to come on this and other exciting plans ahead – 2026 is shaping up to be an important year.

With Gratitude

Thank you to our Patient Partners, Fellows, researchers, clinicians, community organizations, and supporters for your time, insight, and commitment. It is a privilege to do this work together. Wishing you a restful holiday season and a strong start to 2026.

New Co-Designed Publication Shares Best Practices for Patient-Centered Academic Events

We’re excited to share a major milestone for Diabetes Action Canada (DAC): a new peer-reviewed paper, “Partnering for impact: best practices for planning in-person academic events with Patient Partners involvement – Lessons learned from Diabetes Action Canada,” was published in Research Involvement and Engagement in May 2025.

Link here: https://link.springer.com/article/10.1186/s40900-025-00729-9

This paper shares key insights and practical lessons from eight years of DAC’s in-person workshops, gatherings designed not just about people with lived experience of diabetes, but with them at the centre of planning and delivery. Over that time, more than 100 researchers, clinicians, policymakers, and Patient Partners have collaborated to build inclusive, accessible, and impactful spaces for dialogue and learning.

What makes this publication especially meaningful is that it was co-designed and co-written with Patient Partners, from start to finish. Patient Partners played central roles in shaping the research questions, planning the workshop described in the case study, and contributing as authors. This highlights DAC’s approach and commitment to authentic partnership and shared leadership in patient-oriented research.

The paper outlines practical strategies that promoted equitable participation and strengthened collaboration across disciplines; from co-designed agendas and symbolic markers highlighting Patient Partner presentations to facilitated networking opportunities that encouraged meaningful connections. These practices helped address power imbalances, ensure accessibility, and support genuine engagement for all participants.

Already, this work is gaining international attention, reinforcing a simple but powerful message: research spaces are stronger when they are built with, not just for, those most affected. These lessons offer a practical roadmap for organizations committed to moving patient engagement from principle to practice.

Read the full open-access paper here: Partnering for impact: best practices for planning in-person academic events with Patient Partners involvement– Lessons learned from Diabetes Action Canada

Diabetes Action Canada at the 2025 Diabetes Canada Professional Conference

The Diabetes Action Canada team returned from the 2025 Diabetes Canada Professional Conference feeling energized, and inspired by the connections and conversations that shaped a great week. This annual gathering remains one of the few moments where our national community can come together in person, off Zoom, out of email, and reconnect as colleagues, partners, and friends working toward better outcomes for people living with diabetes across Canada.

Bringing the Community Together

This Conference is always a highlight on our calendar. A special thank you to Diabetes Canada for hosting yet another great event. The program created space to share new science, learn from one another, and strengthen relationships that make progress possible. For our team, the week reaffirmed just how powerful patient-oriented research can be when lived experience guides the work.

A Standout Moment: The DAC Breakfast

One of the best parts of the week for our team was our Diabetes Action Canada Breakfast, where the 2025–26 Research-to-Action Fellowship cohort presented their projects. Each Fellow showcased a resource, story, or tool built with, and led by, our Patient Partners, offering creative, practical ways to bring research evidence into everyday life.

You can meet our Fellows here 👉 https://diabetesaction.ca/fellowship-2025-cohort/

Fellowship Project Highlights

1. Stigma Project
Partner: Australian Centre for Behavioural Research in Diabetes

  • Who: Brit Hancock and Fizza Abbas
  • What: When Words Hurt and When They Heal: A Nursing Toolkit on Diabetes Stigma – a training workshop for medical and nursing students focused on empathetic, non-stigmatizing diabetes care. Using real stories, it shows how shame, blame, and stigma surface in clinical encounters and how better language can shift experiences.
  • Why: Directly supports Diabetes Canada’s Change the Conversation campaign and strengthens international collaboration on reducing diabetes stigma.

2. Misdiagnosis Project
Partner: Indigenous Diabetes Health Circle

  • Who: Jeremy Auger and Anmol Budhiraja
  • What: Diabetes Answers for Us: Pocket Cards for Clinic Visits – small, easy-to-use cards reminding people of their rights in the doctor’s office and the questions to ask. They list key diagnostic tests, explain results in plain language, and help people connect symptoms to possible diabetes to get appropriate follow-up.
  • Why: Builds self-advocacy, improves health literacy, and supports culturally grounded diabetes care within Indigenous communities..

3. Women’s Health & Diabetes Project
Partner: Tidepool

  • Who: Maryann Maloney and Wajeeha Cheema
  • What: Things I Learned the Hard Way: Women’s Health & Diabetes Book –  a storytelling e-book sharing first-person experiences across reproductive and hormonal life stages. Drawing on stories from women and gender-diverse people in more than eight countries, it blends lived experience with evidence and practical guidance on diagnosis, puberty, pregnancy, parenting, work, menopause, and aging.
  • Why: Elevates women’s voices and advances patient-driven innovation with an internationally respected nonprofit.

4. Cell Therapy 101 Project
Partner: Alberta Diabetes Institute

  • Who: Alex St. John and Emily Burke-Hall
  • What: Cell Therapy 101: Plain-Language Carousels – a three-part infographic series explaining the past, present, and future of cell therapy. It highlights key milestones from the Edmonton Protocol to today’s innovations, outlining benefits, risks, and gaps. The series is grounded in insights from more than 12 transplant recipients to show the real-life impact of this evolving field.
  • Why: Makes highly technical science accessible for people living with diabetes, supporting Diabetes Canada’s commitment to patient-friendly education.

5. AID-101 Project
Partner: Children with Diabetes

  • Who: Amanda Knight and Najeeb Ashraf
  • What: Pick My Pump: AI Diabetes Tech Chatbot. an AI-powered tool to help parents and adults compare diabetes technologies. It draws only from verified manuals and summarized device information (no web scraping, no guessing) to support informed choices about pumps and algorithms.
  • Why: Responds to a rapidly growing need for clear, unbiased guidance on diabetes technology, a priority for patients, caregivers, and clinicians.

Want to contribute or test some of these projects?
Try our beta tools here 👉 https://linktr.ee/diabetesactioncanada

The room was buzzing with questions, ideas, and new collaborations. It was wonderful to watch our Fellows throughout the week; asking smart questions, sharing their expertise on patient engagement, and connecting with researchers from across Canada. They are a remarkable group and truly represent the next generation of trained patient partners.

Honouring a Leader: Dr. Catharine Whiteside

Another highlight for our team was joining the celebration of Dr. Catharine Whiteside in her retirement. Dr. Whiteside has shaped the diabetes research landscape in Canada in ways that are hard to quantify, but easy to feel. Her leadership, high standards, and unwavering belief in meaningful patient partnership have influenced countless researchers, programs, and organizations. It was truly special to see her honoured by a community she has supported, mentored, and strengthened for so many years.

Spotlight Panel: Low Priority and the Power of Storytelling

A major highlight of the conference was the premiere of Low Priority (Low 2), an arts-based film grounded in the lived experience of people navigating diabetes while facing homelessness, housing instability, or dealing with unstable living conditions and limited support. Co-created with co-researchers from the Calgary Diabetes Advocacy Committee (CDAC), a group of people with lived experience of both diabetes and homelessness, the film exposes realities that rarely appear in clinical guidelines, research papers, or policy frameworks.

The first film, Low, premiered in 2023 and follows Bobby, a person living with type 1 diabetes and navigating the shelter system. It opened conversations about the emotional, social, and practical realities of managing diabetes without a stable home, and the stigma and unconscious bias that can lead to serious adverse events.

Low Priority (Low 2) continues Bobby’s journey as he moves through the hospital system. The film shines a light on what happens in emergency rooms when someone has no fixed address, how assumptions and unconscious bias shape interactions with healthcare workers, how delays in treatment occur, and how the system is simply not designed for people who are managing both diabetes and homelessness. It asks us to confront how quickly snap judgments and structural gaps can lead to real consequences for those already living at the margins.

The panel brought together the filmmaking team, CDAC co-researchers, clinicians, and researchers to discuss how storytelling can:

  • build empathy and reduce stigma
  • surface realities that rarely make it into clinical guidelines
  • push us to rethink how care is delivered
  • deepen our understanding of what truly person-centred care requires

As always, the most powerful insights came from the co-researchers who shaped these films. Their voices, leadership, and generosity are what make this work so impactful.

If you haven’t seen Low you can want the film on our website here:

👉 https://diabetesaction.ca/low/

A Month of Reflection and Gratitude

The conference also coincided with the end of Diabetes Month, an opportunity for our team to pause and appreciate everyone who makes progress possible:

  • the scientists and clinicians whose work turned insulin from an idea into lifesaving reality
  • the patient partners who ask the hardest and most important questions: “What does this mean in real life?”
  • the communities who continually share their stories, time, and trust

From Nobel Prize winning discoveries to modern, co-designed tools and films, progress in diabetes has always relied on partnership.

Looking Ahead

We left this year’s conference inspired by the energy, generosity, and commitment of the diabetes community and incredibly proud of how our Fellows, Patient Partners, and team showed up throughout the week.

Thank you to everyone who joined our sessions, connected with our Fellows, or engaged in conversations about patient-oriented research. We can’t wait to carry this momentum into the year ahead.

Already counting down to next year...Vancouver here we come!

Low 2 Premier at the Diabetes Canada Conference on November 27, 2025

Diabetes Action Canada is pleased to share that Low 2, the second film in this arts-based series co-created with Co-researchers with lived experience from the Calgary Diabetes Advocacy Committee (CDAC), will be screened at the Diabetes Canada Professional Conference on November 27, 2025.

Building on the success of the original film Low, this new chapter continues to illuminate the emotional, social, and practical realities of living with type 1 diabetes, told directly through the voices of those with lived experience.


Research Shows the Impact of Arts-Based Knowledge Mobilization

Earlier this year, the DAC team led by Dr. David Campbell published an evaluation of Low in Health Education & Behavior, demonstrating how arts-based storytelling can deepen understanding of diabetes stigma and improve communication between patients and providers.

Read the full paper here: 👉 https://journals.sagepub.com/doi/10.1177/10901981251332235

The study highlighted several key outcomes:

  • Reduced diabetes stigma by presenting lived experience in an authentic and accessible way.
  • Enhanced empathy and understanding among clinicians, trainees, and policymakers.
  • More patient-centred communication practices, with many viewers reporting meaningful changes in how they support people living with diabetes.
  • Validation and empowerment for individuals who saw their own experiences reflected on screen.

These findings underscore the value of arts-based knowledge mobilization in shifting mindsets and bridging the gap between research evidence and real-world experience.


About Low 2

Low 2 continues the story that began in the original film, offering a deeper look at the lived realities of managing type 1 diabetes and challenging the assumptions that contribute to diabetes stigma in a health care setting.

Co-created with co-researchers with lived experience from the Calgary Diabetes Advocacy Committee (CDAC), the film brings forward honest, nuanced experiences that highlight both the emotional weight and the everyday resilience of life with type 1 diabetes. Their leadership shaped every aspect of the narrative, ensuring the film reflects the community’s voice with authenticity and care.

We are honoured to participate in the premiere of Low 2 at the Diabetes Canada Conference and to share this next chapter with the broader diabetes community. We hope it sparks meaningful conversations about empathy, stigma, and the importance of more human-centred approaches to diabetes care.


Watch Low and Learn More

For those who haven’t yet seen Low, or who want to learn more about the films and the co-creation process behind them, visit our page here:
👉 https://diabetesaction.ca/the-film-low/


When Timing Matters: Reflections from the TIMED Meeting in the Netherlands

November 10th-14th, members of Diabetes Action Canada travelled to Wageningen, Netherlands, to join colleagues from across Canada and the Netherlands for the end-of-grant meeting of the Right Timing to Prevent Type 2 Diabetes (TIMED) Consortium. The gathering marked an important milestone in a collaboration that brings together world-leading chronobiologists, clinicians, implementation scientists, and Patient Partners who have worked collectively to understand how the timing of daily behaviours influences metabolic health.

A partnership built on shared purpose

The TIMED Consortium was created through a 2021 Canada–Netherlands collaboration supported by the Canadian Institutes of Health Research (CIHR), ZonMw, the Dutch Diabetes Research Foundation (Diabetes Fonds), and Health~Holland. Led by Dr. André Carpentier of the Université de Sherbrooke and Dr. Patrick Schrauwen of Maastricht University, the project explores a deceptively simple question: does it matter when we eat, sleep, and move when it comes to preventing type 2 diabetes?

To answer this, the team combined tightly controlled metabolic studies, analyses of longitudinal cohorts, and real-world lifestyle intervention work. Early findings suggest that aligning daily habits with the body’s 24-hour metabolic clock, such as eating earlier in the day or exercising in the afternoon, may play a meaningful role in reducing diabetes risk. The Wageningen meeting was an opportunity for all partners to come together, share results, and consider how these insights might reach the people and communities who could benefit most.

Patient partnership at the centre

A defining feature of TIMED has been its commitment to patient partnership. At the meeting, Diabetes Action Canada Patient Partners Lucie Vaillancourt and Matt Larsen spoke about how their lived experience shaped the research over the past several years, joined by Dutch Patient Partners Jan Willem and Ted Reckman, who shared their own reflections from the Netherlands. A special thanks to Pam Leblanc, whose leadership in patient partnership has supported this work from the beginning and helped ensure that the voices of people living with diabetes remained central throughout the project.

Together, the Patient Partners described their involvement in co-designing interview guides, reviewing findings in plain language, and advising on how knowledge should be shared with the public and with decision-makers. Their contributions highlighted the difference it makes when people with lived experience are not only consulted, but actively engaged in shaping the direction, relevance, and real-world impact of the research. As Matt noted during the session, “What’s the point of creating an intervention if patients won’t be the ones taking it up?”

The response from attendees made clear how meaningful this contribution has been. Many noted that seeing Patient Partners directly engaged in discussions with scientists broadened their understanding of what collaborative research can look like.

Strengthening impact through knowledge mobilization

Diabetes Action Canada was also invited to deliver a workshop on Knowledge Mobilization, focusing on how to ensure that scientific findings reach the audiences who need them and reach them in time to make a difference. The session highlighted practical ways to communicate research more effectively, including using platforms like LinkedIn to share insights quickly, working with Patient Partners to shape dissemination strategies, and preparing clear, accessible messages early in the research process rather than waiting until publication.

The impact of this conversation was felt almost immediately. Shortly after the workshop, partners from the Dutch Diabetes Fund published a public reflection on the TIMED findings that translated complex chronobiology concepts into everyday language, connecting the science to practical choices like eating earlier in the day or exercising later in the afternoon. It was a powerful example of how thoughtful communication can bridge the space between discovery and real-world usefulness.

Reflections from Wageningen

Throughout the week, discussions ranged from emerging physiological findings to the realities of implementing timing-based interventions in diverse communities. Participants explored how metabolic rhythms are disrupted in modern life, how this disruption may contribute to diabetes risk, and how interventions must account for people’s work schedules, cultural contexts, and daily responsibilities. These conversations resonated strongly with Diabetes Action Canada’s work in patient-oriented research and implementation science, particularly in ensuring that innovations remain grounded in feasibility, equity, and lived experience.

Looking ahead

The TIMED Consortium stands as a model for what international, multi-sector research can achieve when scientific expertise, lived experience, and timely knowledge mobilization come together. The partnership has drawn on Canada’s strengths in metabolic imaging and patient-oriented research, combined with the Netherlands’ deep expertise in chronobiology and controlled physiological studies, to build a body of work that is both rigorous and relevant.

The discussions in Wageningen underscored that meaningful impact requires more than scientific breakthroughs; it requires ensuring that people can see themselves in the research and apply its insights in daily life. The relationships built through TIMED will continue to guide how this knowledge moves from lab benches and meeting rooms into communities where it can make a difference.

DAC @ Diabetes Canada Conference 2025

The Diabetes Canada Professional Conference is a key opportunity for our Network to connect, learn, and share progress. This agenda highlights Diabetes Action Canada’s activities throughout the week — from presentations and panels to special events that showcase our collaborative, patient-oriented research.

Wednesday November 26th, 2025

Time SessionSpeakers
13:15 – 16:15DCS1 – Eat Well, Move Smart, Live Strong: A Practical Workshop on Diabetes and Women’s HealthJane Yardley
Cydney Prusky
Nicole “Nikki” Fraser Heslin
Susie Jin
14:45 – 16:15 SPECIAL EVENT
(CanScreen T1D): Can We Prevent Type 1 Diabetes in Canada?
👉 Register here for the CanScreen T1D Symposium

Thursday November 27th, 2025

TimeSessionSpeakers
7:30 – 8:30SPECIAL EVENT FOR MEMBERS:
DAC Networking Breakfast
👉 Register here for the DAC Breakfast
10:30 – 11:45DCS4 – Lifetime Achievement & Early Researcher Awards LecturesDavid Campbell
Rémi Rabasa-Lhoret
14:30 – 15:45DCS8 – Clinical Practice GuidelinesZaina Albalawi
Virginie Blanchette
Barbara J. MacDonald
Arnav Agarwal
Iliana C. Lega
14:30 – 15:45DCS9 – Emerging Adjuvant Therapies in Type 1 Diabetes (& LADA)Melissa-Rosina Pasqua
Alanna Weisman
Nadine Taleb
Sonia Butalia
19:00SPECIAL EVENT
Premiere of Low Priority (Sequel to Low)
👉 Register here to attend the Low Priority premiere

Friday November 28th, 2025

TimeSessionSpeakers
10:30 – 11:45DCS10 – Compassion in Practice: Supporting Clients Through Diabetes Distress and Mental Health ChallengesJessica Kitchler
Ciara Stevens
Sarah Moore-Vasram
Sonja M. Reichert
11:55 – 12:15CC08 – Obesity Treatment in Motion: Navigating Decision Points TogetherSatya Dash
13:00 – 14:14AS04 – Practicalities of screening for kidney disease in diabetesSheldon W. Tobe
Rick Ward
Jo-Anne Wilson
Christopher Tran
Calvin Ke
14:30 – 15:45DCS14 – Complications of DiabetesPedro Geraldes
Vaibhav Patel
Joan Krepinsky
Jacqueline Beaudry
16:00 – 17:15DCS15 – Beyond Basics: Further Topics in Diabetes TechnologyAlanna Weisman
Michael C. Riddell
Rémi Rabasa-Lhoret
Bikrampal Sidhu

Saturday November 29th, 2025

TimeSessionSpeakers
9:15 – 10:30AS05 – Transforming Type 1 Diabetes: Strategies for early detection and delay onset therapeuticsPeter Lin
Peter Senior
Susie Jin
Elizabeth Rosowlowsky
10:45 – 12:00DCS19 – Type 2 Diabetes Remission – Evidence, Impact, and Future DirectionsMegan Racey
Diana Sherifali
Brian McKenna
Mark Ewer
Lindsay Sawatsky
Sonja M. Reichert
13:00 – 14:15ORAL ABSTRACT: DCO3 – Economic Analysis and Return on investment (ROI) for Diabetic Retinopathy (DR) Screening and Treatment through Diabetes Eye Screening Program (DESP) among uninsured patient populations living with diabetes and seeking careAleksandra Stanimirovic